• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down1.10% Nasdaq Down1.82%

    Valeant Pharmaceuticals International, Inc. (VRX)

    89.63 Feb 8, 4:01PM EST
    |Pre-Market : 87.03 Down 2.60 (2.90%) 7:31AM EST - Nasdaq Real Time Price
    Analyst OpinionGet Analyst Opinion for:
    Recommendation Summary*
    Mean Recommendation (this week):2.2
    Mean Recommendation (last week):2.2

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Price Target Summary
    Mean Target:156.67
    Median Target:155.00
    High Target:213.00
    Low Target:90.00
    No. of Brokers:21

    Data provided by Thomson/First Call

    Upgrades & Downgrades History
    DateResearch FirmActionFromTo
    Dec 17, 2015MizuhoDowngradeBuyNeutral
    Nov 2, 2015GoldmanDowngradeBuyNeutral
    Oct 27, 2015MizuhoUpgradeNeutralBuy
    Oct 22, 2015BMO Capital MarketsDowngradeOutperformMarket Perform
    Oct 20, 2015CIBCDowngradeSector OutperformSector Perform
    Oct 9, 2015MizuhoInitiated Neutral
    Oct 2, 2015Morgan StanleyDowngradeOverweightEqual-Weight
    Sep 29, 2015NomuraInitiated Buy
    Feb 9, 2015BarclaysInitiated Overweight
    Oct 30, 2013FBR CapitalInitiated Outperform

    More Upgrades & Downgrades for VRX

    Data provided by Briefing.com - Take a free trial
    Complete Live market analysis of the U.S. stock and bond markets, technology stocks, economic releases, earnings reports, and day trading highlights.

    Recommendation Trends
    Current MonthLast MonthTwo Months AgoThree Months Ago
    Strong Buy5556

    Data provided by Thomson/First Call

    Currency in USD.